Global Nootropics Market Anticipated To Grow To $13.23 Billion By 2030 At 17.4% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, How Much Growth In Market Size Is Expected For The Nootropics Market?
The nootropics market has seen substantial growth in recent years. The market is forecast to increase from $5.96 billion in 2025 to $6.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.9%. This historic growth was influenced by several factors, including the restricted availability of prescription nootropics, insufficient consumer awareness, reliance on traditional stimulants, the elevated cost of advanced cognitive enhancers, and a scarcity of online distribution channels.
The nootropics market size is set for significant expansion over the next few years. It is forecast to increase to $13.23 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 17.4%. This growth throughout the forecast period can be attributed to several factors, including the increasing acceptance of over-the-counter and prescription nootropics, a growing demand for both natural and synthetic blends, the expansion of online and offline distribution networks, an intensified focus on cognitive health and anti-aging solutions, and technological innovations in product formulations and delivery systems. Dominant trends during this period are expected to involve a rising demand for cognitive enhancers and prescription nootropics, the increasing popularity of over-the-counter nootropic supplements, a growing adoption of nootropic drinks and powders, an enhanced focus on memory improvement and mental performance, and greater consumer awareness regarding their benefits for mood, sleep, and anti-aging.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6130&type=smp
Which Major Factors Are Contributing To The Development Of The Nootropics Market?
The growth of the nootropics market is projected to be driven by the rising expenditure on health and wellness moving forward. Health and wellness are commonly understood as a method individuals use to achieve mental and physical well-being. Achieving mental and physical health involves significant engagement with the health and wellness industry. Nootropics are effective in supporting an individual’s health and wellness. Therefore, an increase in demand for healthcare and wellness will lead to a proportional rise in the need for nootropics. For instance, in November 2024, data from the Global Wellness Institute, a US-based research organization, indicated that global expenditure on health and wellness reached US$6.3 trillion in 2023, climbing from US$5.8 trillion in 2022, with forecasts predicting an increase to US$9 trillion by 2028. This growing expenditure on healthcare and wellness is consequently a key driver for the nootropics market.
How Is The Nootropics Market Examined Through Segment Analysis?
The nootropics market covered in this report is segmented –
1) By Drug Type: Prescription Nootropics, Over-The-Counter (OTC) Nootropics
2) By Form: Capsules Or Tablets, Powder, Drinks, Other Forms
3) By Distribution Channel: Offline, Online
4) By Application: Memory Enhancement, Mood And Depression, Attention And Focus, Sleep And Recovery, Anxiety
Subsegments:
1) By Prescription Nootropics: Stimulants, Cognitive Enhancers
2) By Over-The-Counter (OTC) Nootropics: Natural Nootropics, Synthetic Nootropics, Nootropic Blends
Which Trends Are Expected To Shape The Nootropics Market?
Companies operating in the noonan syndrome market are actively developing treatments for various growth-related conditions to improve health and disease management in children. These multiple growth-related disorders involve diverse conditions that affect normal physical development, typically caused by genetic, hormonal, or nutritional factors. For example, in May 2024, BioMarin Pharmaceutical Inc., a US-based biopharmaceutical company, presented positive new data for VOXZOGO (vosoritide) at the 2024 Pediatric Endocrine Society Annual Meeting, emphasizing its effectiveness in treating multiple growth-related conditions in children, including idiopathic short stature (ISS), Noonan syndrome, and achondroplasia. The Phase 2 study demonstrated significant improvements in growth velocity and height for children with various genetic conditions, such as ACAN deficiency and NPR2 mutations. These promising results indicate VOXZOGO’s potential to benefit a broader range of growth disorders beyond its current approval for achondroplasia.
Who Are The Major Companies Operating In The Nootropics Market?
Major companies operating in the nootropics market are Accelerated Intelligence Inc., AlternaScript Inc. Health Via Modern Nutrition Inc., Mental Mojo LLC., Peak Nootropics, PureLife Bioscience Co. Ltd., TruBrain, PepsiCo, Superior Supplement Manufacturing, Equinox Nutraceuticals, Natural Stacks Inc., Gaia Herbs Farms., Kimera Koffee LLC., Onnit Labs LLC., Reckitt Benckiser Group plc., OUTLIERS INC., Teva Pharmaceutical Industries Ltd., United Pharmacies o, Clarity Nootropics, OptiMind, HVMN Inc., BioAdaptives Inc., Powder City
Access The Complete Nootropics Market Report:
https://www.thebusinessresearchcompany.com/report/nootropics-global-market-report
Which Region Leads The Nootropics Market By Size?
North America was the largest region in the nootropics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nootropics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Nootropics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=6130&type=smp
Browse Through More Reports Similar to the Global Nootropics Market 2026, By The Business Research Company
Hepatorenal Syndrome Treatment Global Market Report 2026
Diverticulitis Disease Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report
Hyperpigmentation Disorder Treatment Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.